Un medicamento nuevo podría ser un avance contra el eczema
MIÉRCOLES, 14 de diciembre de 2022 (HealthDay News) — Un medicamento experimental podría algún día ser una cura para el eczema, sugiere un nuevo ensayo.El medicamento, rocatinlimab, es un anticuerpo monoclonal que los investigadores encontraron que p…
Learn MoreRestless Leg Syndrome More Common in Psoriasis Patients
THURSDAY, Dec. 15, 2022 (HealthDay News) — Restless leg syndrome (RLS) is more common in psoriasis patients and is associated with more severe psoriasis, according to a study published online Dec. 5 in the International Journal of Dermatology.Berna S…
Learn MoreValue-Based Outcome Set Developed for Psoriasis
THURSDAY, Dec. 15, 2022 (HealthDay News) — A value-based outcome set (VOS) has been developed for psoriasis, according to an article published online Dec. 7 in the Journal of the European Academy of Dermatology and Venereology.Niels Timo Hilhorst, M….
Learn MoreRocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis
THURSDAY, Dec. 15, 2022 (HealthDay News) — The anti-OX40 antibody rocatinlimab is effective for adults with confirmed atopic dermatitis with moderate-to-severe disease activity, according to a study published online Dec. 9 in The Lancet.Emma Guttman-…
Learn MoreGene Therapy Gel Offers New Hope Against Rare Blistering Disease
THURSDAY, Dec. 15, 2022 (HealthDay News) — An experimental gene therapy that’s applied as a skin gel appears to heal wounds caused by a rare and severe genetic skin disease.Experts called the findings “remarkable,” and said they bring hope of a bette…
Learn MoreCluster Headaches Often Joined by Other Illnesses
THURSDAY, Dec. 15, 2022 (HealthDay News) — Having short, painful headaches for many days or even weeks in a row may signal that you’re more likely to have other medical woes, researchers say.These “cluster headaches” are extremely painful and can las…
Learn MoreEven in Advanced Liver Disease, It’s Never Too Late to Quit Alcohol
THURSDAY, Dec. 15, 2022 (HealthDay News) — Quitting alcohol can help reduce complications of liver cirrhosis, even in patients who have advanced disease. It can also help them live longer, new research shows. “Our results clearly show that all patien…
Learn MoreLa mayoría de las personas con EPOC disfrutan de una buena salud mental, según un estudio
MARTES, 13 de diciembre de 2022 (HealthDay News) — Sorprendentemente, la mayoría de las personas que sufren de enfermedad pulmonar obstructiva crónica (EPOC) tienen una excelente salud mental, informan unos investigadores canadienses.Dos tercios de l…
Learn MoreOdds of Migraine Up With Median, Multiple Nerve Decompressions
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Patients who undergo upper-extremity nerve decompression for median nerve compression or multiple nerve decompressions have increased odds of migraine, according to a study published in the December issue o…
Learn MoreNew Drug Might Be Advance Against Eczema
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — An experimental drug may one day be a cure for eczema, a new trial suggests.The drug, rocatinlimab, is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condi…
Learn More